Well then with respect to Copax we'll have the same story. Mnta receives approval for mcopax and ampha or somebody like that will do the same thing ( i am assuming mnta has patented some copax related IPs ). If this case is dismissed like you say it could be, it is really bad for mnta only because it is small and the business it is in.